JPRN-UMIN000003979
Recruiting
未知
A pilot study of efficacy and safety of aprepitant with chemoradiotherapy involving weekly cisplatin in patients with cervical cancer. - A pilot study of aprepitant with CCRT
ara Medical University0 sites30 target enrollmentAugust 6, 2010
Conditionscervical cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- cervical cancer
- Sponsor
- ara Medical University
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. patients with received pimozide. 2\. patients with history of chemotherapy with cisplatin. 3\. patients with vomiting within 24 hours before first administrating of cisplatin. 4\. patients who have had any other cancer. 5\. patients who are pregnant or breast feeding. 6\. patients with severe complications (heart disease, uncontrolled diabetes,bleeding tendency). 7\. patients with active infection disease whom steroid is inappropriate for. 8\. patients who have a history of hypersensitivity to drugs. 9\. patients who were administered drugs in the following, 5\-HT3 blocker, phenothiazine, butyrophenone, benzamide, dopamine receptor antagonist. 10\. patients who are considered to be inappropriate for this study judged by the treating physician.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapyunresectable advanced colorectal cancerJPRN-UMIN000019876Takeda Pharmaceutical Company Limited52
Active, not recruiting
Not Applicable
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMajor Depressive DisorderMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSEUCTR2008-003359-58-GBCPS Research60
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patientsISRCTN86839890Transcend Medical, Inc.™ (USA)20
Active, not recruiting
Phase 1
A preliminary study to assess if low dose iron is safe and effective in patients with inflammatory bowel diseaseIron deficiency anaemia in inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851MedDRA version: 20.1Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2018-002982-20-GBRoyal Liverpool University Hospital30